Electrical stimulation treatment patch for male premature ejaculation

Abstract

The invention belongs to the technical field of medical supplies, and discloses an electrical stimulation treatment patch for male premature ejaculation, comprising: an electrical stimulation chip for generating an electrical pulse signal; the control circuit board is used for controlling parameters of the electric pulse signals; the button cell is used for supplying power to the electrical stimulation chip and the control circuit board; the electrode patch is used for transmitting an electric pulse signal to the perineum area of the patient, and the electrode patch integrates the electric stimulation chip, the control circuit board and the button battery to form an integrated structure. According to the scheme, a non-invasive low-frequency nerve regulation and control technology is provided, rhythmic contraction of globular cavernous muscles is inhibited through electric pulse signals, the incubation period of ejaculation is prolonged, dependence of chemical drugs and irritant components is avoided, and higher safety and effectiveness are achieved.

Description

Technical Field

[0001] The present invention relates to the technical field of medical supplies, and more specifically, to an electrostimulation therapy patch for male premature ejaculation. Background Art

[0002] Premature ejaculation is the most common one among male sexual dysfunctions, and its pathogenesis is complex, involving multiple aspects such as nerves, endocrine, muscles, and psychology. The ejaculation reflex is that the skin of the penis, prepuce, and glans penis (sensors) receive stimuli and are transmitted through the dorsal penile nerve (afferent nerve) (an important branch of the pudendal nerve) to the spinal cord (T10 - T12). A part of its efferent impulses is transmitted through the sympathetic nerve to the vas deferens, seminal vesicles, prostate, etc., causing sudden contraction of the smooth muscles of these organs and sending semen to the urethra. Another part of the efferent impulses is transmitted through the pudendal nerve to the ischiocavernosus muscle and bulbocavernosus muscle (belonging to striated muscles), causing these muscles to contract in a clonic manner and ejecting semen from the urethra out of the body. The erection center (S1 - 3) is innervated by the pelvic splanchnic nerve (parasympathetic nerve) and the hypogastric nerve (sympathetic nerve). When the pelvic splanchnic nerve is excited, it causes the arterioles to dilate and leads to erection. The ejaculation center (S2 - 4) controls the ejaculation of semen through the rhythmic contraction of the ischiocavernosus and bulbocavernosus muscles innervated by the pudendal nerve.

[0003] Currently, the existing methods for treating premature ejaculation include drug treatment, delay spray, and surgical treatment, but all have certain side effects. ①Drug treatment: Such as dapoxetine. Mainly due to limited efficacy and an increase in side effects with long-term use, it is difficult for patients to adhere to the use. ②Delay spray: Although it has a certain effect in the short term, most of them contain irritating ingredients such as alcohol and Chinese prickly ash, which may cause local numbness, skin irritation, loss of pleasure, etc. Long-term use may even damage the local skin barrier and cause inflammation. The pungent alcohol smell or the smell of traditional Chinese medicine may make the partner feel embarrassed and affect the intimate experience of both partners. ③Surgical treatment: In some patients, the number of dorsal penile nerves is excessive, resulting in overly strong sexual stimulation signals and easy reaching of the excitation threshold, thus causing premature ejaculation. Such patients may undergo surgery to remove some dorsal penile nerves, but the surgical effect is unstable. Removing too little cannot improve the sensitivity problem, while removing too much may lead to the risk of functional loss. Summary of the Invention

[0004] The purpose of the present invention is to solve the drawbacks existing in the prior art and propose an electrostimulation therapy patch for male premature ejaculation.

[0005] To solve the above problems in the background art, the present invention adopts the following technical solutions:

[0006] An electrostimulation therapy patch for male premature ejaculation, comprising:

[0007] An electrostimulation chip for generating an electrical pulse signal;

[0008] A control circuit board for controlling the parameters of an electrical pulse signal;

[0009] A button battery for powering the electrical stimulation chip and the control circuit board;

[0010] An electrode patch for transmitting the electrical pulse signal to the perineal area of the patient. The electrode patch integrates the electrical stimulation chip, the control circuit board, and the button battery to form an integrated structure.

[0011] As a further solution of the present invention: A central processor, a power switch, a boost system, an H-bridge, and a drive system are provided on the control circuit board, and the electrical stimulation chip and the button battery are installed on the control circuit board.

[0012] As a further solution of the present invention: The electrical pulse signal is a biphasic symmetric square wave, with a frequency range of 1 Hz - 150 Hz, a pulse width range of 50 μs - 1000 μs, a current range of 0 mA - 20 mA, and an electrode impedance range of 1 kΩ - 6 kΩ.

[0013] As a further solution of the present invention: The electrode patch is attached to the ischiocavernosus muscle or the bulbocavernosus muscle in the perineal area of the patient.

[0014] As a further solution of the present invention: The electrical stimulation therapy patch is a disposable device

[0015] Compared with the prior art, the advantages of the present invention are as follows:

[0016] First, this solution provides a non-invasive low-frequency neuromodulation technique. By suppressing the rhythmic contraction of the bulbocavernosus muscle through an electrical pulse signal, it prolongs the ejaculation latency and avoids dependence on chemical drugs and irritating components, with higher safety and effectiveness.

[0017] Second, the device of this solution has an integrated design, occupies a small space, has a low cost, and is convenient to carry and use. By using the TES technology to suppress the rhythmic contraction of the bulbocavernosus muscle, it significantly prolongs the ejaculation latency and improves male sexual function. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 It is a schematic structural diagram of the present invention;

[0019] Figure 2 It is a schematic diagram of the product after integration of the electrode patch of the present invention;

[0020] Figure 3 It is a pulse schematic diagram of the present invention.

[0021] Description of the reference numerals in the figures:

[0022] 1. Electrical stimulation chip; 2. Control circuit board; 21. Central processing unit; 22. Power switch; 23. Boost system; 24. H-bridge and drive system; 3. Button battery; 4. Electrode patch. Detailed implementation manner

[0023] Next, the technical solutions in the embodiments of the present invention will be clearly and completely described in conjunction with the accompanying drawings in the embodiments of the present invention; obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

[0024] Please refer to Figures 1-3 , an electrical stimulation therapy patch for male premature ejaculation, comprising: an electrical stimulation chip 1, a control circuit board 2, a button battery 3 and an electrode patch 4. The electrode patch 4 integrates the electrical stimulation chip 1, the control circuit board 2 and the button battery 3 to form an integrated structure, making the overall structure occupy less space, lower cost and more convenient to use. The electrical stimulation therapy patch is a disposable device, which is convenient to carry and operate.

[0025] Electrical stimulation chip 1: used to generate a bipolar symmetric square wave electrical pulse signal, with a frequency range of 1 Hz - 150 Hz, a pulse width range of 50 μs - 1000 μs, and a current range of 0 mA - 20 mA. The electrical pulse signal inhibits the contraction of the bulbocavernosus muscle through neuromuscular electrical stimulation (TES) technology, and prolongs the ejaculation time. By using non-invasive neuromodulation stimulation, it can get rid of the dependence on chemical drugs and irritating components.

[0026] Control circuit board 2: used to adjust the parameters of the electrical pulse signal to ensure the accuracy and safety of the treatment. The control circuit board 2 is provided with a central processing unit 21, a power switch 22, a boost system 23, and an H-bridge and drive system 24. The central processing unit 21 is responsible for executing the instructions stored in the memory, processing data and coordinating the work of other functional components. The boost system 23 is mainly a boost boost circuit, which is used to boost the power supply to ensure the stimulation intensity. The H-bridge and drive system 24 is used for waveform conversion of the stimulation to ensure the effectiveness of the stimulation scheme. The power switch 22 is used to switch the power supply.

[0027] Button battery 3: provides power for the electrical stimulation chip and the control circuit board to ensure the portability of the device. The electrical stimulation chip 1 and the button battery 3 are installed on the control circuit board 2.

[0028] Electrode patch 4: Transmits electrical pulse signals to the ischiocavernosus muscle and bulbocavernosus muscle in the perineal area of the patient, delivers corresponding electrical pulses to the pelvic floor muscles to trigger the contraction of the corresponding muscles, so as to improve, enhance, inhibit or assist in relaxing and dilating the pelvic floor muscles, inhibit the rhythmic contraction during ejaculation, prolong the ejaculation time, and thus improve male sexual function.

[0029] The following is a case of using the above electrical stimulation therapy patch:

[0030] Example 1

[0031] ● Basic information:

[0032] Name: Wang

[0033] Gender: Male

[0034] Age: 28 years old

[0035] Height: 173 cm

[0036] Weight: 65 kg

[0037] BMI index: 21.7

[0038] ● Vital signs:

[0039] Heart rate: 76 beats / min; Blood pressure: 120 / 80 mmHg;

[0040] Quiet breathing: 18 times / min; Body temperature: 36.8 °C;

[0041] ● Physical examination:

[0042] Skin integrity: Intact;

[0043] ● Stimulation parameters

[0044] Output waveform: Biphasic symmetric square wave

[0045] Current intensity: 10 mA

[0046] Stimulation frequency: 30 Hz

[0047] Pulse width: 400 us

[0048] Stimulation time: 20 min

[0049] Intervention period: 2 weeks

[0050] ● Ejaculation latency time:

[0051] Ejaculation latency time before intervention: 260 s;

[0052] Ejaculation latency time after intervention: 450 s.

[0053] Example 2

[0054] ● Basic information:

[0055] Name: Liu

[0056] Gender: Male

[0057] Age: 32 years old

[0058] Height: 175 cm

[0059] Weight: 78 kg

[0060] BMI index: 25.4

[0061] ● Vital signs:

[0062] Heart rate: 78 beats / min; Blood pressure: 130 / 85 mmHg;

[0063] Quiet breathing: 20 breaths / min; Body temperature: 36.7 °C;

[0064] ● Physical examination:

[0065] Skin integrity: Intact;

[0066] ● Stimulation parameters

[0067] Output waveform: Biphasic symmetric square wave

[0068] Current intensity: 15 mA

[0069] Stimulation frequency: 40 Hz

[0070] Pulse width: 400 us

[0071] Stimulation time: 20 min

[0072] Intervention period: 2 weeks

[0073] ● Ejaculation latency time:

[0074] Ejaculation latency time before intervention: 310 s;

[0075] Ejaculation latency time after intervention: 530 s.

[0076] In summary: The device transiently inhibits the contraction of the bulbocavernosus muscle based on transcutaneous electrical nerve stimulation (TES). TES is delivered to the neuromuscular junction, and it can maintain muscle contraction at about 80%. By maintaining partial muscle contraction and / or by driving, it inhibits the ability of the muscle to exhibit rhythmic contractions during the neural ejaculation stimulation phase. Therefore, this bulbocavernosus muscle TES can clinically prolong the intravaginal ejaculation latency time (IELT) (prolong sexual intercourse time).

[0077] As described above, it is only the preferred specific implementation manner of the present invention; however, the protection scope of the present invention is not limited thereto. For example, in the actual use of this technical product, the circuit design can be set in rechargeable and non-rechargeable ways. Any person skilled in the art within the technical scope disclosed by the present invention, making equivalent substitutions or changes according to the technical solution of the present invention and its improved conceptions, shall be covered by the protection scope of the present invention.

Claims

1. An electrical stimulation patch for treating male premature ejaculation, characterized in that: include: An electrical stimulation chip (1), used for generating an electrical pulse signal; A control circuit board (2), used for controlling the parameters of the electric pulse signal; A button battery (3), used to supply power to the electrical stimulation chip and the control circuit board; The electrode patch (4) is used to transmit an electric pulse signal to the perineum area of ​​a patient. The electrode patch (1) integrates an electric stimulation chip (1), a control circuit board (2) and a button battery (3) to form an integrated structure.

2. The electrical stimulation treatment patch for male premature ejaculation according to claim 1, characterized in that: The control circuit board (2) is provided with a central processing unit (21), a power switch (22), a boost system (23), and an H-bridge and drive system (24), and the electrical stimulation chip (1) and the button battery (3) are mounted on the control circuit board (2).

3. The electrical stimulation patch for treating male premature ejaculation according to claim 1, characterized in that: The electric pulse signal is a two-phase symmetrical square wave with a frequency range of 1 Hz-150 Hz, a pulse width range of 50 μs-1000 μs, a current range of 0 mA-20 mA, and an electrode impedance range of 1 kΩ-6 kΩ.

4. The electrical stimulation patch for treating male premature ejaculation according to claim 1, characterized in that: The electrode patch (4) is attached to the ischiocavernosus muscle or the bulbospongosus muscle in the perineum area of ​​the patient.

5. The electrical stimulation patch for treating male premature ejaculation according to claim 1, characterized in that: The electrical stimulation therapeutic patch is a disposable device.

Images